adalimumab

FDA Decision On Interchangeable Exclusivity Allows Pfizer To Rival Boehringer On Adalimumab
Generics Bulletin
Mon, 10/9/23 - 11:35 pm
Pfizer
Humira
biosimilars
adalimumab
AbbVie
interchangeability
FDA
Amgen prepped to take first slice of AbbVie’s US Humira pie
BioProcess International
Wed, 01/18/23 - 11:00 pm
Amgen
Humira
biosimilars
adalimumab
Amjevita
180 Life Sciences Provides Update on Correspondence Received from U.K. and U.S. Regulatory Authorities on Pathway for a Therapy That Could Prevent Progression of Early-Stage Dupuytren’s Disease
BioSpace
Tue, 06/14/22 - 09:00 pm
180 Life Sciencs
FDA
MHRA
Dupuytren's Contracture
Dupuytren's disease
adalimumab
AbbVie's Battle Royale
TheStreet.com
Wed, 09/14/16 - 09:25 am
AbbVie
patents
adalimumab
Humira
Abbott Labs
Phase 3 successful for Amgen's adalimumab biosimilar
Seeking Alpha
Wed, 10/8/14 - 10:09 am
Amgen
adalimumab
biosimilars
Humira
ABP 501